Evidence map›Paper›PMID 38873033›Full record

ArticleDigital discovery2024

Mining patents with large language models elucidates the chemical function landscape.

Clayton W Kosonocky, Claus O Wilke, Edward M Marcotte, Andrew D Ellington

Abstract read
In one paragraph

Article in Digital discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Clayton W KosonockyDepartment of Molecular Biosciences, University of Texas at Austin Austin TX 78705 USA.ORCID https://orcid.org/0000-0002-6420-8615
Claus O WilkeDepartment of Integrative Biology, University of Texas at Austin Austin TX 78705 USA.ORCID https://orcid.org/0000-0002-7470-9261
Edward M MarcotteDepartment of Molecular Biosciences, University of Texas at Austin Austin TX 78705 USA.ORCID https://orcid.org/0000-0001-8808-180X
Andrew D EllingtonDepartment of Molecular Biosciences, University of Texas at Austin Austin TX 78705 USA.ORCID https://orcid.org/0000-0001-6246-5338

Funding

Proteomics and model organism humanization to decode human geneticsR35GM122480 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI EDWARD M MARCOTTE · 2017 to 2026
$5.4M
NIGMS NIH HHS R35 GM122480
6 · The paper itself

Abstract

The fundamental goal of small molecule discovery is to generate chemicals with target functionality. While this often proceeds through structure-based methods, we set out to investigate the practicality of methods that leverage the extensive corpus of chemical literature. We hypothesize that a sufficiently large text-derived chemical function dataset would mirror the actual landscape of chemical functionality. Such a landscape would implicitly capture complex physical and biological interactions given that chemical function arises from both a molecule's structure and its interacting partners. To evaluate this hypothesis, we built a Chemical Function (CheF) dataset of patent-derived functional labels. This dataset, comprising 631 K molecule-function pairs, was created using an LLM- and embedding-based method to obtain 1.5 K unique functional labels for approximately 100 K randomly selected molecules from their corresponding 188 K unique patents. We carry out a series of analyses demonstrating that the CheF dataset contains a semantically coherent textual representation of the functional landscape congruent with chemical structural relationships, thus approximating the actual chemical function landscape. We then demonstrate through several examples that this text-based functional landscape can be leveraged to identify drugs with target functionality using a model able to predict functional profiles from structure alone. We believe that functional label-guided molecular discovery may serve as an alternative approach to traditional structure-based methods in the pursuit of designing novel functional molecules.

Identifiers

PMID38873033
PMCPMC11167698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.